ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

7.75
0.00
( 0.00% )
Actualizado: 18:00:00

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
7.75
Postura de Compra
7.80
Postura de Venta
7.85
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
7.75
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
24,458,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-466.67
Beneficio por acción (BPA)
-0.01
turnover
113.05M
Beneficio neto
-214k

Acerca de Medexus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Blank Checks
Sitio web
Sede
Bolton, Gbr
Fundado
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7.75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 0.00 to $ 0.00.

Medexus Pharmaceuticals currently has 24,458,000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $189.55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -466.67.

MDP Últimas noticias

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MDP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Medexus Pharmaceuticals?
El precio actual de las acciones de Medexus Pharmaceuticals es $ 7.75
¿Cuántas acciones de Medexus Pharmaceuticals están en circulación?
Medexus Pharmaceuticals tiene 24,458,000 acciones en circulación
¿Cuál es la capitalización de mercado de Medexus Pharmaceuticals?
La capitalización de mercado de Medexus Pharmaceuticals es CAD 189.55M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Medexus Pharmaceuticals?
Medexus Pharmaceuticals ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Medexus Pharmaceuticals?
El ratio precio/beneficio de Medexus Pharmaceuticals es -466.67
¿Cuál es el ratio de efectivo a ventas de Medexus Pharmaceuticals?
El ratio de efectivo a ventas de Medexus Pharmaceuticals es 0.88
¿Cuál es la moneda de reporte de Medexus Pharmaceuticals?
Medexus Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Medexus Pharmaceuticals?
El último ingresos anual de Medexus Pharmaceuticals es USD 113.05M
¿Cuál es el último beneficio anual de Medexus Pharmaceuticals?
El último beneficio anual de Medexus Pharmaceuticals es USD -214k
¿Cuál es la dirección registrada de Medexus Pharmaceuticals?
La dirección registrada de Medexus Pharmaceuticals es 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
¿Cuál es la dirección del sitio web de Medexus Pharmaceuticals?
La dirección del sitio web de Medexus Pharmaceuticals es www.medexus.com
¿En qué sector industrial opera Medexus Pharmaceuticals?
Medexus Pharmaceuticals opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MVYMoovly Media Inc
$ 0.01
(100.00%)
39k
CTGCentenario Gold Corp
$ 0.02
(100.00%)
650.1k
CTACentaurus Energy Inc
$ 2.90
(63.84%)
4.1k
TOHTotal Helium Ltd
$ 0.015
(50.00%)
3k
KSKlondike Silver Corp
$ 0.015
(50.00%)
118.33k
ADG.HArcus Development Group Inc
$ 0.005
(-66.67%)
11k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
20k
MNLXMiniluxe Holding Corp
$ 0.465
(-38.00%)
4.4k
WAVEWaverley Pharma Inc
$ 0.01
(-33.33%)
4k
MTLOMartello Technologies Group Inc
$ 0.01
(-33.33%)
22k
XBOTRealbotix Corp
$ 0.66
(8.20%)
6.47M
QNCQuantum Emotion Corp
$ 0.70
(-22.22%)
3.65M
WWTWater Ways Technologies Inc
$ 0.005
(0.00%)
2.1M
THRMTherma Bright Inc
$ 0.045
(12.50%)
1.57M
GPUSAlset AI Ventures Inc
$ 0.17
(-8.11%)
1.46M
lakers17 lakers17 17 segundos hace
Yield sign on CRGA. Are they going to file?
RKMKE RKMKE 23 segundos hace
THis seems starting.. Consider, they got some state contracts... moon baby moon.
GEVI
koolmc koolmc 27 segundos hace
bid 6 million at .0002 and 4.5 million at .0004 ask, i'm sure they are hiding some orders at .0003
EEGI
BlazingStocks BlazingStocks 28 segundos hace
$ILLR Social Media Today Article January 09, 2025

Triller Launches App to Download Your TikTok Clips
https://www.socialmediatoday.com/news/triller-launches-tiktok-download-tool/736972/
ILLR
glenn1919 glenn1919 36 segundos hace
MULN.................................................slapthebottom.............https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=2&dy=12&id=p84071410134
MULN
Investor2014 Investor2014 44 segundos hace
When I navigate to the January edition: Volume 12, Issue 1, January 2025 and scroll down to Article 100016 - I get what I posted!
AVXL
EisMCA2 EisMCA2 50 segundos hace
We should be just into the stage of the worms eating and growing for 4 weeks, if my timing is correct. The next batch of spinning cocoons should hit the last week of January, and be done with the 3 days of spinning by end of January or first few days of February. They can't pause between batches sin
KBLB
firebag1 firebag1 55 segundos hace
SAVA??
SANA
StockItOut StockItOut 1 minuto hace
It's fake dude.
XERI
RKMKE RKMKE 1 minuto hace
Possible someone know somthing... Harp cannot sit quietly... He also need $$$ for living.. imo
BRLL
gdog gdog 1 minuto hace
1-13 S STZ $187.10 +$5.11 share
STZ
sumbuysumsell sumbuysumsell 1 minuto hace
Yes. Same here. Very positive.
Also reads that Juan Carlos Lopez-Talavera, MD, PhD, Head of Research and Development of Anavex Is still with Anavex.
Good times ahead.
AVXL
WarMachine WarMachine 2 minutos hace
Market sure doesn't seem to be thrilled over the upcoming launch(?) announcement scheduled for tomorrow evening. I guess all of the followers from the elite internet gurus and Reggies kids aren't sucking up all the available shares so they can change their zipcodes when the price goes TO THE MOON! l
MONI
drkazmd65 drkazmd65 2 minutos hace
NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
6:31 AM ET 1/13/25 | Dow Jones
SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-s
NNVC
Hardazoak Hardazoak 2 minutos hace
Benny is taking us to 8 dollar land.
AABB
Scratchgolf Scratchgolf 2 minutos hace
Just to give everyone another example on how JB can make money by doing nothing. Already 3.5 million shares have been bought today. That is $350. Multiply that by 365 comes out to $127 thousand . A very good living can be made by these CEO's off of these penny stocks.
I am not sure who is
UBQU
RKMKE RKMKE 2 minutos hace
Seems to me Harp is getting serious
BRLL
art2426 art2426 2 minutos hace
>>>WHICH CATALYST WILL BE FIRST?
BIEL
Hardazoak Hardazoak 2 minutos hace
100%
AABB
trender18 trender18 2 minutos hace
NFTM has very strong support at $.16. Current Price
0.461
Bid
0.1632
Ask
0.398
NFTM
Huggy Bear Huggy Bear 2 minutos hace
They are running out of marks to buy shares. Doesn't mean they aren't trying to dilute as much as possible.
HMBL
Trooperstocks Trooperstocks 2 minutos hace
$SGTM SOWING SUSTAINABILITY. HARVESTING HOPE.
RESTORING THE PLANET. ONE YARD AT A TIME.

https://img1.wsimg.com/isteam/ip/9f8df632-1291-4de6-ae2e-6cd4239755a5/IMG_3542.webp/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:875,h:875,cg:true
SGTM
koolmc koolmc 3 minutos hace
hopefully there timeline is sooner rather then later
EEGI
vlispxpert vlispxpert 3 minutos hace
I don't have X account, I never sign up for anything that requires information...This is a big thing I hate about X...forced registration to read/post comments...I liked the old system as I could read comments, now I can't, so I'm not a fan & rarely look at posts much...
vein vein 3 minutos hace
That would be nice 
CKPT

Su Consulta Reciente

Delayed Upgrade Clock